Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 02
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Inogen Inc
INGN
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$5.98
0.71
13.47%
Dern. MÀJ: Oct 2, 5:16 AM
$6.05
0.78
14.8%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Fusions et acquisitions:
Inogen (INGN) announced it will sell assets to Rotech Healthcare, on Wednesday, September 30, 2026 for $25M paid in cash
Inogen Financials
Inogen (INGN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
Inogen (NASDAQ:INGN) lowers FY2026 sales outlook from $366.000 million-$373.000 million to $355.000 million-$361.000 million vs $369.267 million estimate.
Benzinga Newsdesk
PRO
Inogen Sees Q3 Sales $92.400M vs $98.967M Est
Inogen (NASDAQ:INGN) sees Q3 sales of $92.400 million vs $98.967 million analyst estimate.
Benzinga Newsdesk
PRO
Inogen Q2 Sales $95.084M Miss $95.233M Estimate
Inogen (NASDAQ:INGN) reported quarterly sales of $95.084 million which missed the analyst consensus estimate of $95.233 million by 0.16 percent. This is a 3.04 percent increase over sales of $92.277 million the same
Benzinga Newsdesk
PRO
Inogen Affirms FY2026 Sales Guidance of $366.000M-$373.000M vs $369.267M Est
Inogen (NASDAQ:INGN) affirms FY2026 sales outlook from $366.000 million-$373.000 million to $366.000 million-$373.000 million vs $369.267 million estimate.
Benzinga Newsdesk
PRO
Inogen Sees Q2 Sales $94.000M-$97.000M vs $97.250M Est
Inogen (NASDAQ:INGN) sees Q2 sales of $94.000 million-$97.000 million vs $97.250 million analyst estimate.
Benzinga Newsdesk
PRO
Inogen Q1 Adj. EPS $(0.14) Beats $(0.28) Estimate, Sales $85.109M Beat $82.350M Estimate
Inogen (NASDAQ:INGN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.28) by 50 percent. This is a 27.27 percent decrease over losses of $(0.11) per share from the same
Benzinga Newsdesk
